These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 32422075)

  • 1. Leukocyte telomere length and
    Morais M; Dias F; Resende T; Nogueira I; Oliveira J; Maurício J; Teixeira AL; Medeiros R
    Future Oncol; 2020 Jun; 16(18):1245-1255. PubMed ID: 32422075
    [No Abstract]   [Full Text] [Related]  

  • 2. Association of human telomerase reverse transcriptase gene polymorphisms, serum levels, and telomere length with renal cell carcinoma risk and pathology.
    de Martino M; Taus C; Lucca I; Hofbauer SL; Haitel A; Shariat SF; Klatte T
    Mol Carcinog; 2016 Oct; 55(10):1458-66. PubMed ID: 26294352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HTERT promoter methylation and single nucleotide polymorphism (-245 T>C) affect renal cell carcinoma behavior in Serbian population.
    Trifunovic J; Basta Jovanovic G; Nikolic N; Carkic J; Marjanovic A; Brankovic M; Radojevic Skodric S; Prvanovic M; Jovanovic A; Dzamic Z; Milasin J
    J BUON; 2018; 23(6):1887-1892. PubMed ID: 30610818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of TERC Single Nucleotide Polymorphisms with Human Leukocyte Telomere Length and the Risk of Type 2 Diabetes Mellitus.
    Al Khaldi R; Mojiminiyi O; AlMulla F; Abdella N
    PLoS One; 2015; 10(12):e0145721. PubMed ID: 26720590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic Variants Related to Longer Telomere Length are Associated with Increased Risk of Renal Cell Carcinoma.
    Machiela MJ; Hofmann JN; Carreras-Torres R; Brown KM; Johansson M; Wang Z; Foll M; Li P; Rothman N; Savage SA; Gaborieau V; McKay JD; Ye Y; Henrion M; Bruinsma F; Jordan S; Severi G; Hveem K; Vatten LJ; Fletcher T; Koppova K; Larsson SC; Wolk A; Banks RE; Selby PJ; Easton DF; Pharoah P; Andreotti G; Freeman LEB; Koutros S; Albanes D; Mannisto S; Weinstein S; Clark PE; Edwards TE; Lipworth L; Gapstur SM; Stevens VL; Carol H; Freedman ML; Pomerantz MM; Cho E; Kraft P; Preston MA; Wilson KM; Gaziano JM; Sesso HS; Black A; Freedman ND; Huang WY; Anema JG; Kahnoski RJ; Lane BR; Noyes SL; Petillo D; Colli LM; Sampson JN; Besse C; Blanche H; Boland A; Burdette L; Prokhortchouk E; Skryabin KG; Yeager M; Mijuskovic M; Ognjanovic M; Foretova L; Holcatova I; Janout V; Mates D; Mukeriya A; Rascu S; Zaridze D; Bencko V; Cybulski C; Fabianova E; Jinga V; Lissowska J; Lubinski J; Navratilova M; Rudnai P; Szeszenia-Dabrowska N; Benhamou S; Cancel-Tassin G; Cussenot O; Bueno-de-Mesquita HB; Canzian F; Duell EJ; Ljungberg B; Sitaram RT; Peters U; White E; Anderson GL; Johnson L; Luo J; Buring J; Lee IM; Chow WH; Moore LE; Wood C; Eisen T; Larkin J; Choueiri TK; Lathrop GM; Teh BT; Deleuze JF; Wu X; Houlston RS; Brennan P; Chanock SJ; Scelo G; Purdue MP
    Eur Urol; 2017 Nov; 72(5):747-754. PubMed ID: 28797570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The TERT locus genotypes of rs2736100-CC/CA and rs2736098-AA predict shorter survival in renal cell carcinoma.
    Ma R; Liu C; Lu M; Yuan X; Cheng G; Kong F; Lu J; Strååt K; Björkholm M; Ma L; Xu D
    Urol Oncol; 2019 May; 37(5):301.e1-301.e10. PubMed ID: 30738744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomere length in peripheral blood lymphocytes related to genetic variation in telomerase, prognosis and clinicopathological features in breast cancer patients.
    Kroupa M; Rachakonda S; Vymetalkova V; Tomasova K; Liska V; Vodenkova S; Cumova A; Rossnerova A; Vodickova L; Hemminki K; Soucek P; Kumar R; Vodicka P
    Mutagenesis; 2020 Dec; 35(6):491-497. PubMed ID: 33367858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukocyte telomere length and renal cell carcinoma survival in two studies.
    Callahan CL; Schwartz K; Ruterbusch JJ; Shuch B; Graubard BI; Lan Q; Cawthon R; Baccarelli AA; Chow WH; Rothman N; Hofmann JN; Purdue MP
    Br J Cancer; 2017 Aug; 117(5):752-755. PubMed ID: 28742796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia and renal cell carcinoma: The influence of HIF1A+1772C/T functional genetic polymorphism on prognosis.
    Ferreira M; Teixeira A; Maurício J; Lobo F; Morais A; Medeiros R
    Urol Oncol; 2017 Aug; 35(8):532.e25-532.e30. PubMed ID: 28476527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Relative Leucocyte Telomere Length and Gene Single Nucleotide Polymorphisms (
    Vaiciulis P; Liutkeviciene R; Liutkevicius V; Vilkeviciute A; Gedvilaite G; Uloza V
    Cancer Genomics Proteomics; 2020; 17(4):431-439. PubMed ID: 32576588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukocyte telomere length is associated with aggressive prostate cancer in localized prostate cancer patients.
    Xu J; Chang WS; Tsai CW; Bau DT; Xu Y; Davis JW; Thompson TC; Logothetis CJ; Gu J
    EBioMedicine; 2020 Feb; 52():102616. PubMed ID: 31981976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukocyte Telomere Length Shortening, hTERT Genetic Polymorphisms and Risk of Childhood Acute Lymphoblastic Leukemia.
    Eskandari E; Hashemi M; Naderi M; Bahari G; Safdari V; Taheri M
    Asian Pac J Cancer Prev; 2018 Jun; 19(6):1515-1521. PubMed ID: 29936725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shorter Leukocyte Telomere Length coupled with lower expression of Telomerase Genes in patients with Essential Hypertension.
    Cheng G; Wang L; Dai M; Wei F; Xu D
    Int J Med Sci; 2020; 17(14):2180-2186. PubMed ID: 32922179
    [No Abstract]   [Full Text] [Related]  

  • 14. Functional haplotypes of the hTERT gene, leukocyte telomere length shortening, and the risk of peripheral arterial disease.
    Zhang W; Chen Y; Yang X; Fan J; Mi X; Wang J; Zhang C; Hu FB; Hui R
    PLoS One; 2012; 7(10):e47029. PubMed ID: 23082138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MDM2 SNP309 polymorphism as risk factor for susceptibility and poor prognosis in renal cell carcinoma.
    Hirata H; Hinoda Y; Kikuno N; Kawamoto K; Suehiro Y; Tanaka Y; Dahiya R
    Clin Cancer Res; 2007 Jul; 13(14):4123-9. PubMed ID: 17634539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined Influence of EGF+61G>A and TGFB+869T>C Functional Polymorphisms in Renal Cell Carcinoma Progression and Overall Survival: The Link to Plasma Circulating MiR-7 and MiR-221/222 Expression.
    Teixeira AL; Dias F; Ferreira M; Gomes M; Santos JI; Lobo F; Maurício J; Machado JC; Medeiros R
    PLoS One; 2014; 10(4):e0103258. PubMed ID: 25909813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms in human telomerase reverse transcriptase (hTERT) gene and susceptibility to gastric cancer in a Turkish population: Hospital-based case-control study.
    Bayram S; Ülger Y; Sümbül AT; Kaya BY; Genç A; Rencüzoğullari E; Dadaş E
    Gene; 2016 Jul; 585(1):84-92. PubMed ID: 27016301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of vascular endothelial growth factor polymorphisms with clinical outcome of renal cell carcinoma patients.
    Zhong W; Wang X; Pan B; Su Z
    Tumour Biol; 2014 Oct; 35(10):9839-45. PubMed ID: 24989926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Augmented telomerase activity, reduced telomere length and the presence of alternative lengthening of telomere in renal cell carcinoma: plausible predictive and diagnostic markers.
    Pal D; Sharma U; Khajuria R; Singh SK; Kakkar N; Prasad R
    Gene; 2015 May; 562(2):145-51. PubMed ID: 25769384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The miR(21/10b) ratio as a prognostic marker in clear cell renal cell carcinoma.
    Fritz HKM; Lindgren D; Ljungberg B; Axelson H; Dahlbäck B
    Eur J Cancer; 2014 Jul; 50(10):1758-1765. PubMed ID: 24793999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.